Virtuix gets Nasdaq notice: MVLS under $50M minimum, 180-day cure period to March 29, 2027

Virtuix Holdings Inc.

Nasdaq Staff notified Virtuix on September 30, 2026 that MVLS fell below the $50,000,000 minimum under Listing Rule 5450(b)(2)(A) over Aug 18-Sep 29, 2026.
Company also fails Rule 5450(b)(3)(A), the alternative total assets and total revenue standard for continued listing on the Nasdaq Global Market.
Cure deadline is March 29, 2027; compliance is regained if MVLS closes at $50M or more for at least 10 consecutive business days.
Notice has no immediate effect: Class A common stock continues trading on Nasdaq under 'VTIX'; if uncured, Staff would issue a delisting notice appealable to a Nasdaq Hearings Panel.
Virtuix says it will monitor MVLS and may apply to transfer its listing to the Nasdaq Capital Market, subject to Nasdaq approval; no assurance of regaining compliance.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.